1. United States of America Stocks

  2. •

    Financial Services

  3. •

    Shell Companies
Nouveau Life Pharmaceuticals, Inc.

Nouveau Life Pharmaceuticals, Inc.

NOUV
Nouveau Life Pharmaceuticals, Inc.US flagOther OTC
0.00
USD
- -
- -
90,000.00Market Cap
2003 Y
2004 Y
2005 Y
2006 Y
2007 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
-0.01
-0.01
-0.02
-0.01
-0.01
-0.02
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
Book Value per Share
-0.07
-0.08
-0.09
-0.09
-0.1
-0.1
Tangible Book Value per Share
-0.04
-0.04
-0.04
-0.03
-0.01
-0.01
Basic Weighted Avg Shares
22
22
24
26
28
30
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
- -
- -
- -
- -
-1
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
Working Capital
-1
-1
-1
-1
-1
-1
LT Debt
- -
- -
- -
- -
- -
- -
Total Equity
-1
-1
-1
-1
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Sep'08
Dec'08
Mar'08
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
30
30
30
Market Capitalization
7
6
5

Working Capital

FRC

•

in mil. unless spec.
Sep'08
Dec'08
Mar'08
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
1
1
1
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-136.36%
Free Cash Flow
- -
- -
-73.03%
Net Income, GAAP
- -
- -
39.11%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2006
- -
- -
- -
- -
- -
2007
- -
- -
- -
- -
- -
2008
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2006
- -
- -
- -
- -
-0.01
2007
- -
- -
- -
- -
-0.01
2008
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2006
- -
- -
- -
- -
- -
2007
- -
- -
- -
- -
- -
2008
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Brian Shibley
Sector
Financial Services
Industry
Shell Companies
Address
401 East Las Olas Boulevard Ft. Lauderdale FL United States of America 33301
IPO Date
Feb 21, 2003
Website
nouveaulife.com
Similar Companies
Roth CH Acquisition IV Co. (ROCGU)
Tech and Energy Transition Corporation (TETCU)
Eureka Acquisition Corp Unit (EURKU)
Motive Capital Corp. (MOTV-UN)
Voyager Acquisition Corp. (VACH)
China De Xiao Quan Care Group Co., Ltd (CDXQ)
Business
Nouveau Life Pharmaceuticals, Inc. functions as a development stage enterprise, concentrating its efforts on innovative healthcare solutions. The company is actively engaged in the creation and deployment of non-face-to-face care services, including the SeniorGo.ai social communication platform designed for the global senior population. This platform offers diverse media, alongside information pertaining to medical services, insurance, pharmacy, finance, and entertainment. While exploring robotic and AI-driven healthcare devices, the company acknowledges the inherent uncertainties in these ventures regarding both success and profitability. Historically, the organization focused on developing nutraceutical products and natural wellness alternatives. The entity, originally incorporated in 1998 under the name Polo Equities, later operated as Hybrid Fuels, Inc., before adopting the Nouveau Life Pharmaceuticals, Inc. designation in May 2012. The company maintains its operational base in Los Angeles, California, and operates as a subsidiary of EMG Marketing Solutions, Inc.